Thrombosis related to emergency factor VIIa treatment

Anaesthesia

Volumn 58, Issue 12, 2003, Pages 1245-

  Brown, J L ^a   Varma, S ^a   Morgan Hughes, N J ^a   Rocco, G ^a  

^a NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; BLOOD CLOTTING FACTOR 7A; DESMOPRESSIN;

ADULT; ARTERIOVENOUS FISTULA; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; EMERGENCY TREATMENT; EMPYEMA; FOLLOW UP; HEMOFILTRATION; HUMAN; INTENSIVE CARE UNIT; LETTER; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; SECOND LOOK SURGERY; THORACOTOMY; THROMBOCYTE TRANSFUSION; THROMBOSIS; TREATMENT OUTCOME;

EID: 0345116129     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2044.2003.03547.x     Document Type: Letter

References (3)

1. Jurlander B, Thim L, Klausen NK, et al. Recombinant activated factor VII (rFVIIa): Characterization, manufacturing and clinical development. Seminars in Thrombosis and Hemostasis 2001; 27: 373-84.
2. Worth LL, Hoots WK. Development of a subdural vein thrombosis following aggressive factor VII replacement for post natal intracranial haemorrhage in a homozygous factor VII-deficient infant. Haemophilia 1998; 5: 757-61.
3. Heuer L, Blumberg D. Recombinant factor VIIa - A new option in intractable bleeding? International Journal of Intensive Care 2003; 10: 73-80.